ESSA Pharma (EPIX) Institutional Ownership $1.72 -0.04 (-2.27%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ESSA Pharma (NASDAQ:EPIX)CurrentInstitutional OwnershipPercentage75.12%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$22.58MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$7.80M Get EPIX Insider Trade Alerts Want to know when executives and insiders are buying or selling ESSA Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EPIX Institutional Buying and Selling by Quarter Ad Darwin2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] ESSA Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 RTW Investments LP3,261,496$19.77M0.3%+41.9%7.351% 11/15/2024 Parkman Healthcare Partners LLC345,902$2.10M0.3%+37.2%0.780% 11/14/2024 Bellevue Group AG7,879,583$47.75M0.8%-0.1%17.759% 11/14/2024 PFM Health Sciences LP2,742,936$16.62M0.9%-7.5%6.182% 5/16/2024 Janus Henderson Group PLC1,175,242$9.98M0.0%+7.9%2.657% 5/15/2024 Bellevue Group AG7,889,583$66.98M1.0%-0.1%17.834% Get the Latest News and Ratings for EPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. 5/14/2024 EntryPoint Capital LLC4,420$38K0.0%N/A0.010% 5/1/2024 BNP Paribas Financial Markets42,495$361K0.0%-26.1%0.096% 2/15/2024 PFM Health Sciences LP3,262,500$21.53M1.3%-22.3%7.388% 2/14/2024 RTW Investments LP2,298,662$15.17M0.2%N/A5.205% 2/7/2024 BNP Paribas Financial Markets57,466$379K0.0%+164.9%0.130% 11/15/2023 Rock Springs Capital Management LP677,005$2.09M0.1%+2.1%1.535% 11/9/2023 Group One Trading L.P.41,860$129K0.0%-14.2%0.095% 11/9/2023 Rhenman & Partners Asset Management AB234,000$723K0.1%-34.4%0.531% 8/14/2023 Rock Springs Capital Management LP663,317$1.79M0.0%+26.4%1.504% 8/14/2023 Driehaus Capital Management LLC28,300$76K0.0%-89.3%0.064% 8/11/2023 Cibc World Market Inc.160,643$434K0.0%-23.1%0.364% 7/26/2023 Privium Fund Management B.V.20,032$55K0.0%N/A0.045% 5/16/2023 Ally Bridge Group NY LLC236,583$703K0.9%-70.8%0.537% 5/12/2023 Rhenman & Partners Asset Management AB356,500$1.05M0.1%-4.9%0.809% 5/3/2023 Privium Fund Management UK Ltd20,032$61K0.0%N/A0.045% 2/15/2023 Avidity Partners Management LP1,855,400$4.68M0.1%-24.6%4.208% 2/14/2023 Driehaus Capital Management LLC264,571$667K0.0%N/A0.600% 2/3/2023Frazier Life Sciences Management L.P.605,141$1.53M0.1%-12.7%1.373% 11/15/2022 PFM Health Sciences LP1,478,252$2.69M0.1%+53.7%3.354% 11/15/2022 Eventide Asset Management LLC1,561,251$2.84M0.1%-53.6%3.543% 11/15/2022 BVF Inc. IL8,748,629$15.92M0.7%+136.5%19.852% 11/15/2022 Bellevue Group AG5,898,583$10.74M0.2%+17.7%13.385% 11/15/2022 Bioimpact Capital LLC405,700$738K0.2%-38.6%0.921% 11/14/2022 RTW Investments LP1,311,294$2.39M0.1%-50.3%2.975% 11/10/2022 AlpInvest Partners B.V.39,930$73K0.0%-62.5%0.091% 8/12/2022 Ensign Peak Advisors Inc26,282$83K0.0%-70.6%0.060% 8/11/2022 Trexquant Investment LP19,147$60K0.0%+24.3%0.043% 8/11/2022 Alps Advisors Inc.26,140$82K0.0%N/A0.059% 8/10/2022 Cibc World Market Inc.94,578$298K0.0%-17.9%0.215% 8/8/2022 Walleye Capital LLC104,393$329K0.0%+75.8%0.237% 8/3/2022 Candriam S.C.A.567,343$1.79M0.0%-3.5%1.289% 5/17/2022 Eventide Asset Management LLC4,170,259$25.77M0.4%+25.7%9.474% 5/16/2022 Blackstone Inc.2,003,103$12.38M0.0%-39.4%4.551% 5/16/2022Frazier Life Sciences Management L.P.692,910$4.28M0.4%N/A1.574% 2024's Must-Watch Stocks! (Ad)Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now]5/9/2022 Qube Research & Technologies Ltd47,655$295K0.0%N/A0.108% 5/4/2022 Prospera Financial Services Inc7,568$47K0.0%N/A0.017% 5/2/2022 Cannon Global Investment Management LLC15,300$95K0.1%N/A0.035% 4/27/2022Alta Wealth Advisors LLC11,285$70K0.0%N/A0.026% 3/10/2022 Values First Advisors Inc.13,668$194K0.1%N/A0.031% 2/19/2022 Woodline Partners LP684,247$9.72M0.1%+286.6%1.556% 2/15/2022 CIBC World Markets Inc.84,230$1.20M0.0%N/A0.192% 2/14/2022 Virtus ETF Advisers LLC13,643$194K0.1%+74.3%0.031% 2/14/2022 Altium Capital Management LP345,000$4.90M1.4%N/A0.784% 2/14/2022 Boxer Capital LLC724,500$10.29M0.4%+5.5%1.647% 2/14/2022 Soleus Capital Management L.P.3,525,457$50.06M5.0%+22.9%8.015% 2/14/2022 Eventide Asset Management LLC3,318,647$47.13M0.6%+52.2%7.545% 2/11/2022 Ensign Peak Advisors Inc89,448$1.27M0.0%+7.7%0.203% 2/11/2022 Bioimpact Capital LLC668,688$9.50M1.7%-2.1%1.520% 2/10/2022 Candriam Luxembourg S.C.A.626,276$8.89M0.1%+108.4%1.424% 2/8/2022Frazier Management LLC543,470$7.72M0.6%+51.7%1.236% 2/8/2022 Swiss National Bank53,200$755K0.0%+8.4%0.121% 2/3/2022 Advisor Group Holdings Inc.4,559$65K0.0%-28.8%0.010% 12/17/2021Jefferies Group LLC62,502$500K0.0%N/A0.142% 11/16/2021 Schonfeld Strategic Advisors LLC10,600$85K0.0%-87.8%0.024% 11/16/2021 Janus Henderson Group PLC3,477,844$27.84M0.0%+72.4%7.907% 11/16/2021 Two Sigma Advisers LP564,800$4.52M0.0%+1,319.1%1.284% 11/16/2021 Two Sigma Investments LP502,406$4.02M0.0%+1,658.9%1.142% 11/16/2021 BVF Inc. IL2,851,461$22.81M0.9%+16.3%6.483% 11/16/2021 BioImpact Capital LLC683,287$5.47M0.8%N/A1.553% 11/16/2021 Citadel Advisors LLC685,531$5.49M0.0%-4.9%1.559% 11/15/2021 RTW Investments LP2,637,192$21.10M0.3%-13.6%5.996% 11/15/2021 Rock Springs Capital Management LP508,044$4.06M0.1%+1.0%1.155% 11/15/2021 Sphera Funds Management LTD.469,402$3.76M0.3%-27.6%1.067% 11/15/2021 HighVista Strategies LLC143,566$1.15M0.8%+497.5%0.326% 11/15/2021 Ensign Peak Advisors Inc83,068$665K0.0%-53.4%0.189% 11/12/2021 Renaissance Technologies LLC141,500$1.13M0.0%+618.3%0.322% 11/12/2021 Macquarie Group Ltd.6,106$49K0.0%N/A0.014% 11/12/2021Credit Suisse AG13,713$110K0.0%+12.2%0.031% 11/12/2021 Oppenheimer & Co. Inc.47,300$378K0.0%N/A0.108% 11/12/2021 Bellevue Group AG5,034,814$40.28M0.4%+104.7%11.447% 11/12/2021 Rhenman & Partners Asset Management AB600,000$4.80M0.3%+130.8%1.364% 11/10/2021 Goldman Sachs Group Inc.121,601$973K0.0%+82.1%0.276% 11/10/2021 Alliancebernstein L.P.49,231$394K0.0%+212.7%0.112% 11/9/2021Barclays PLC77,300$618K0.0%N/A0.176% 11/9/2021BlackRock Inc.81,638$653K0.0%+23.0%0.186% 11/8/2021 Swiss National Bank49,100$393K0.0%+4.2%0.112% 11/5/2021 Advisor Group Holdings Inc.6,401$51K0.0%-72.4%0.015% 11/4/2021 Deutsche Bank AG43,701$350K0.0%+2,696.0%0.099% 8/25/2021 Marshall Wace LLP14,479$414K0.0%N/A0.036% 8/25/2021Marshall Wace North America L.P.273,413$7.81M0.0%+50.2%0.676% 8/17/2021 Sphera Funds Management LTD.648,303$18.52M1.3%+38.2%1.602% 8/17/2021 Price T Rowe Associates Inc. MD24,303$694K0.0%N/A0.060% 8/17/2021 Acuta Capital Partners LLC232,896$6.65M2.7%-18.9%0.576% 8/17/2021 BVF Inc. IL2,451,561$70.04M2.6%-15.7%6.060% The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here.8/17/2021 Citadel Advisors LLC720,701$20.59M0.0%+48.1%1.781% 8/16/2021 Blackstone Inc3,303,103$94.37M0.2%-7.6%8.165% 8/16/2021 Commodore Capital LP281,911$8.05M2.8%+59.4%0.697% 8/16/2021 Morgan Stanley496,809$14.19M0.0%-13.3%1.228% 8/16/2021Credit Suisse AG12,226$348K0.0%N/A0.030% 8/16/2021 Schonfeld Strategic Advisors LLC87,056$2.49M0.0%-14.8%0.215% 8/16/2021 Maven Securities LTD17,711$512K0.0%-36.9%0.044% 8/16/2021 Omega Fund Management LLC328,196$9.38M1.6%-2.6%0.811% 8/16/2021 Goldman Sachs Group Inc.66,774$1.91M0.0%+62.9%0.165% 8/16/2021 Marshall Wace LLP14,479$414K0.0%N/A0.036% (Data available from 1/1/2016 forward) EPIX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EPIX shares? During the previous two years, 17 institutional investors and hedge funds held shares of ESSA Pharma. The most heavily invested institutionals were Bellevue Group AG ($47.75M), RTW Investments LP ($19.77M), PFM Health Sciences LP ($16.62M), Janus Henderson Group PLC ($9.98M), Avidity Partners Management LP ($4.68M), Parkman Healthcare Partners LLC ($2.10M), and Rock Springs Capital Management LP ($2.09M).Learn more on EPIX's institutional investors. What percentage of ESSA Pharma stock is owned by institutional investors? 75.12% of ESSA Pharma stock is owned by institutional investors. Learn more on EPIX's institutional investor holdings. Which institutional investors have been buying ESSA Pharma stock? Of the 9 institutional investors that purchased ESSA Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($3.26M), Driehaus Capital Management LLC ($264.57K), Rock Springs Capital Management LP ($152.06K), Parkman Healthcare Partners LLC ($93.83K), Janus Henderson Group PLC ($85.76K), BNP Paribas Financial Markets ($35.77K), and Privium Fund Management B.V. ($20.03K). How much institutional buying is happening at ESSA Pharma? Institutional investors have bought a total of 3,937,973 shares in the last 24 months. This purchase volume represents approximately $23.77M in transactions. Which ESSA Pharma major shareholders have been selling company stock? Of the 10 institutional investors that sold ESSA Pharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: PFM Health Sciences LP ($1.16M), Avidity Partners Management LP ($604.60K), Ally Bridge Group NY LLC ($574.97K), Driehaus Capital Management LLC ($236.27K), Rhenman & Partners Asset Management AB ($141K), Frazier Life Sciences Management L.P. ($87.77K), and Cibc World Market Inc. ($48.15K). How much institutional selling is happening at ESSA Pharma? Institutional investors have sold a total of 2,892,894 shares in the last 24 months. This volume of shares sold represents approximately $12.47M in transactions. Related Companies C4 Therapeutics Major Shareholders uniQure Major Shareholders iTeos Therapeutics Major Shareholders Immutep Major Shareholders biote Major Shareholders Kodiak Sciences Major Shareholders Atea Pharmaceuticals Major Shareholders Mersana Therapeutics Major Shareholders Atai Life Sciences Major Shareholders Poseida Therapeutics Major Shareholders This page (NASDAQ:EPIX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
